Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 27

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 21, 2009; 15(27): 3426-3430
Published online Jul 21, 2009. doi: 10.3748/wjg.15.3426

Full Size Figure Download Figure

Figure 2 Postoperative clinical course of patient 2.

Citation: Kamar N, Lavayssière L, Muscari F, Selves J, Guilbeau-Frugier C, Cardeau I, Esposito L, Cointault O, Nogier MB, Peron JM, Otal P, Fort M, Rostaing L. Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation. World J Gastroenterol 2009; 15(27): 3426-3430
URL: https://www.wjgnet.com/1007-9327/full/v15/i27/3426.htm
DOI: https://dx.doi.org/10.3748/wjg.15.3426

Kamar N, Lavayssière L, Muscari F, Selves J, Guilbeau-Frugier C, Cardeau I, Esposito L, Cointault O, Nogier MB, Peron JM, Otal P, Fort M, Rostaing L. Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation. World J Gastroenterol 2009; 15(27): 3426-3430 [PMID: 19610146 DOI: 10.3748/wjg.15.3426]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.